亨廷顿舞蹈症和精神分裂症患者死后大脑中的多巴胺与去甲肾上腺素 - Suppr

Suppr

超能文献

Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.

作者信息

Bird E D, Spokes E G, Iversen L L

出版信息

Acta Psychiatr Scand Suppl. 1980;280:63-73.

PMID:6447433

Abstract

摘要

相似文献

Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.亨廷顿舞蹈症和精神分裂症患者死后大脑中的多巴胺与去甲肾上腺素

Acta Psychiatr Scand Suppl. 1980;280:63-73.

Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].精神分裂症患者死后大脑中的多巴胺和高香草酸浓度[会议论文集]

J Physiol. 1979 Aug;293:36P-37P.

Abnormal neuroleptic/dopamine receptors in schizophrenia.精神分裂症中异常的抗精神病药物/多巴胺受体。

Adv Biochem Psychopharmacol. 1980;21:435-42.

The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。

Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.

Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.死后中枢神经系统和垂体中多巴胺 D2 样受体的测量：精神分裂症的区域差异变化

Life Sci. 2004 May 7;74(25):3115-31. doi: 10.1016/j.lfs.2003.11.004.

Dopaminergic abnormalities in postmortem schizophrenic brain.

Adv Biochem Psychopharmacol. 1980;24:325-33.

Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients.

Lancet. 1979 Feb 3;1(8110):237-9. doi: 10.1016/s0140-6736(79)90767-0.

Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.死于精神分裂症的患者大脑边缘区域多巴胺浓度升高。

Brain. 1979 Jun;102(2):347-60. doi: 10.1093/brain/102.2.347.

Increased brain dopamine and dopamine receptors in schizophrenia.精神分裂症患者大脑中的多巴胺及多巴胺受体增加。

Arch Gen Psychiatry. 1982 Sep;39(9):991-7. doi: 10.1001/archpsyc.1982.04290090001001.

Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.帕金森病中脑去甲肾上腺素水平与多巴胺丢失之间的负相关关系：去甲肾上腺素可能具有神经保护作用。

Arch Neurol. 2006 Dec;63(12):1724-8. doi: 10.1001/archneur.63.12.1724.

引用本文的文献

Spatiotemporal Up-Regulation of Mu Opioid Receptor 1 in Striatum of Mouse Model of Huntington's Disease Differentially Affecting Caudal and Striosomal Regions.亨廷顿舞蹈病小鼠模型纹状体中μ阿片受体1的时空上调对尾侧和纹状小体区域产生不同影响

Front Neuroanat. 2020 Dec 10;14:608060. doi: 10.3389/fnana.2020.608060. eCollection 2020.

Noradrenergic Modulation of Cognition in Health and Disease.健康与疾病状态下认知的去甲肾上腺素能调节

Neural Plast. 2017;2017:6031478. doi: 10.1155/2017/6031478. Epub 2017 May 3.

Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.亨廷顿病大鼠模型中的决策受损与抑制控制丧失

Front Behav Neurosci. 2016 Oct 26;10:204. doi: 10.3389/fnbeh.2016.00204. eCollection 2016.

The role of dopamine in Huntington's disease.多巴胺在亨廷顿舞蹈症中的作用。

Prog Brain Res. 2014;211:235-54. doi: 10.1016/B978-0-444-63425-2.00010-6.

Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons.缺乏或抑制多巴胺能刺激会导致纹状体酪氨酸羟化酶阳性中间神经元的发育增加。

PLoS One. 2012;7(9):e44025. doi: 10.1371/journal.pone.0044025. Epub 2012 Sep 18.

Lessons learned from the transgenic Huntington's disease rats.从转基因亨廷顿病大鼠中获得的经验教训。

Neural Plast. 2012;2012:682712. doi: 10.1155/2012/682712. Epub 2012 Jul 18.

Differential electrophysiological changes in striatal output neurons in Huntington's disease.亨廷顿病患者纹状体输出神经元的电生理差异变化。

J Neurosci. 2011 Jan 26;31(4):1170-82. doi: 10.1523/JNEUROSCI.3539-10.2011.

High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers.出生后早期发育阶段纹状体多巴胺能神经元数量较多：与多巴胺能纤维的相关性分析

J Neural Transm (Vienna). 2008 Oct;115(10):1375-83. doi: 10.1007/s00702-008-0112-x. Epub 2008 Aug 29.

Hemiballism-hemichorea and non-ketotic hyperglycaemia.偏身投掷-舞蹈症与非酮症高血糖症

J Neurol Neurosurg Psychiatry. 1994 Jun;57(6):748-50. doi: 10.1136/jnnp.57.6.748.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验